Literature DB >> 8418371

Wheat germ agglutinin affinity of murine hemopoietic stem cell subpopulations is an inverse function of their long-term repopulating ability in vitro and in vivo.

R E Ploemacher1, J C van der Loo, C A van Beurden, M R Baert.   

Abstract

Hemopoietic stem cells show extensive heterogeneity with respect to their proliferative potential and activity. We have recently reported that the accepted technique for sorting stem cells on the basis of high affinity for the lectin wheat germ agglutinin (WGA) did not select for cells initiating long-term production of new stem cells on a stromal layer in vitro. We have therefore reinvestigated the expression of cell surface sialic acid residues in the hemopoietic stem cell compartment by sorting murine bone marrow cells on the basis of affinity for WGA. Frequency analysis of long-term bone marrow culture initiating stem cells was done using the cobblestone-area-forming cell (CAFC) assay with limiting dilution set-up. In vivo stem cell quality was determined by spleen colony formation, marrow-repopulating ability (MRA) and long-term repopulating ability (LTRA) using sex-mismatched hemopoietic chimerism. The data indicate that MRA and LTRA in vivo and in vitro are among the most WGA-dim cells. In contrast, the enrichment factors for splenic colony-forming units (CFU-S) at day 12 and transient CAFC increase with increasing WGA affinity. These characteristics allowed us to concentrate LTRA cells 590- to 850-fold over their activity in normal bone marrow without significant enrichment of day-12 CFU-S. The data reveal that WGA affinity is an inverse function of the primitiveness of murine hemopoietic stem cells and that long-term production of blood cells in vivo and in vitro is provided for by primitive cells that are physically separable from the vast majority of day-12 CFU-S. In addition the data reveal, that the CAFC frequency at day 28-35 of a graft strongly correlates with the number of cells required to induce 40% donor-type chimerism at 15 months post-transplantation and thus predicts the in vivo LTRA of a graft.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8418371

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  7 in total

Review 1.  Regulatory pathways in blood-forming tissue with particular reference to gap junctional communication.

Authors:  M Rosendaal ; T Krenács T
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

2.  The early phase of engraftment after murine blood cell transplantation is mediated by hematopoietic stem cells.

Authors:  J M Zijlmans; J W Visser; L Laterveer; K Kleiverda; D P Heemskerk; P M Kluin; R Willemze; W E Fibbe
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

3.  An in vitro model for cytogenetic conversion in CML. Interferon-alpha preferentially inhibits the outgrowth of malignant stem cells preserved in long-term culture.

Authors:  J J Cornelissen; R E Ploemacher; B W Wognum; A Borsboom; H C Kluin-Nelemans; A Hagemeijer; B Löwenberg
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

4.  Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulating ability.

Authors:  J M Zijlmans; J W Visser; K Kleiverda; P M Kluin; R Willemze; W E Fibbe
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

5.  Intrinsic and extrinsic control of hemopoietic stem cell numbers: mapping of a stem cell gene.

Authors:  G de Haan; G Van Zant
Journal:  J Exp Med       Date:  1997-08-18       Impact factor: 14.307

6.  Phenotypic analysis of murine long-term hemopoietic reconstituting cells quantitated competitively in vivo and comparison with more advanced colony-forming progeny.

Authors:  M Trevisan; N N Iscove
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

7.  Relationships between ablation of distinct haematopoietic cell subsets and the development of donor bone marrow engraftment following recipient pretreatment with different alkylating drugs.

Authors:  J D Down; A Boudewijn; J H Dillingh; B W Fox; R E Ploemacher
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.